Tzu Chi Medical Journal
Volume 19, Issue 3 , Pages 159-163, September 2007

Intermediate Syndrome After Organophosphate Ingestion

  • Yen-Ta Huang

      Affiliations

    • Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Department of Emergency Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Institute of Toxicology and Pharmacology, Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung Yang Road, Hualien, Taiwan
  • ,
  • Pei-Chun Lai

      Affiliations

    • Department of Pediatrics, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Integrative Physiology and Clinical Sciences, Tzu Chi University, Hualien, Taiwan
  • ,
  • Chien-Yu Su

      Affiliations

    • Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Yi-Ting Chen

      Affiliations

    • Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Chuan-Zhong Cai

      Affiliations

    • Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Chih-Hsien Wang

      Affiliations

    • Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Medical Informatics, Tzu Chi University, Hualien, Taiwan

Received 21 December 2006; received in revised form 4 January 2007; accepted 13 February 2007.

Article Outline

Abstract 

Organophosphate poisoning is not uncommon in Taiwan. However, no case of intermediate syndrome (IMS) has been published. We report a case of delayed-onset IMS presenting with abrupt respiratory failure following the acute cholinergic crisis of phenthoate poisoning. Based on electrophysi-ological studies from the literature, IMS results from an excess amount of acetylcholine at neuromuscular junction nicotinic acetylcholine receptors due to prolonged inhibition of acetylcholinesterase. This phenomenon leads to downregulation of the acetylcholine receptor and promotes muscle weakness. There are still no appropriate parameters to predict the development of IMS. Perhaps electrophysiological studies can be applied in the future. Ventilatory support is the most important treatment; the benefits of pra-lidoxime treatment are still controversial. IMS is still a challenging complication of organophosphate poisoning. Physicians should not overlook IMS.

Keywords:  Intermediate syndrome , Organophosphate poisoning , Phenthoate

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lin CL , Yang CT , Pan KY , Huang CC . Most common intoxication in nephrology ward organophosphate poisoning . Ren Fail . 2004;26:349–354
  2. Lee WC , Yang CC , Deng JF , et al.   The clinical significance of hyperamylasemia in organophosphate poisoning . J Toxicol Clin Toxicol . 1998;36:673–681
  3. Karalliedde L . Organophosphorus poisoning and anaesthesia . Anaesthesia . 1999;54:1073–1088
  4. Satoh T , Hosokawa M . Organophosphates and their impact on the global environment . Neurotoxicology . 2000;21:223–227
  5. Dharmani C , Jaga K . Epidemiology of acute organophosphate poisoning in hospital emergency room patients . Rev Environ Health . 2005;20:215–232
  6. Venkatesh S , Kavitha ML , Zachariah A , Oommen A . Progression of type I to type II paralysis in acute organophosphorous poisoning: is oxidative stress significant? . Arch Toxicol . 2006;80:354–361
  7. Senanayake N , Karalliedde L . Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome . N Engl J Med . 1987;316:761–763
  8. Karalliedde L , Baker D , Marrs TC . Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy . Toxicol Rev . 2006;25:1–14
  9. Leon-S FE , Pradilla G , Vesga E . Neurological effects of organophosphate pesticides . BMJ . 1996;313:690–691
  10. Hsieh BH , Deng JF , Ger J , Tsai WJ . Acetylcholinesterase inhibition and the extrapyramidal syndrome: a review of the neurotoxicity of organophosphate . Neurotoxicology . 2001;22:423–427
  11. Mahieu P , Hassoun A , Van Binst R , Lauwerys R , Deheneffe Y . Severe and prolonged poisoning by fenthion. Significance of the determination of the anticholinesterase capacity of plasma . J Toxicol Clin Toxicol . 1982;19:425–432
  12. Gadoth N , Fisher A . Late onset of neuromuscular block in organophosphorus poisoning . Ann Intern Med . 1978;88:654–655
  13. Gutmann L , Besser R . Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations . Semin Neurol . 1990;10:46–51
  14. Smith AP . Long-term effects of the anticholinesterases sarin and soman on latencies of muscle action potentials in mouse diaphragm muscle . J Pharm Pharmacol . 1993;45:176–181
  15. De Bleecker J , Van den Abeele K , De Reuck J . Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates . Neurotoxicology . 1994;15:331–340
  16. De Wilde V , Vogelaers D , Colardyn F , et al.   Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome . Klin Wochenschr . 1991;69:177–183
  17. Shailesh KK , Pais P , Vengamma B , Muthane U . Clinical and electrophysiological study of intermediate syndrome in patients with organophosphorous poisoning . J Assoc Physicians India . 1994;42:451–453
  18. Avasthi G , Singh G . Serial neuron-electrophysiological studies in acute organophosphate poisoning–correlation with clinical findings, serum cholinesterase levels and atropine dosages . J Assoc Physicians India . 2000;48:794–799
  19. Aygun D, Doganay Z, Altintop L, Guven H, Onar M, Deniz T, et al. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning . J Toxicol Clin Toxicol . 2002;40:903–910
  20. Bissbort SH , Vermaak WJ , Elias J , Bester MJ , Dhatt GS , Pum JK . Novel test and its automation for the determination of erythrocyte acetylcholinesterase and its application to organophosphate exposure . Clin Chim Acta . 2001;303:139–145
  21. Thiermann H , Szinicz L , Eyer P , Zilker T , Worek F . Correlation between red blood cell acetylcholineste rase activity and neuromuscular transmission in organo phosphate poisoning . Chem Biol Interact . 2005;157–158:345–347
  22. du Toit PW , Muller FO , van Tonder WM , Ungerer MJ . Experience with the intensive care management of organophosphate insecticide poisoning . S Afr Med J . 1981;60:227–229
  23. Aygun D . Diagnosis in an acute organophosphate poisoning: report of three interesting cases and review of the literature . Eur J Emerg Med . 2004;11:55–58
  24. Worek F , Kirchner T , Backer M , Szinicz L . Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds . Arch Toxicol . 1996;70:497–503
  25. Kassa J , Cabal J . A comparison of the efficacy of a new asymmetric bispyridinium oxime BI–6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods . Hum Exp Toxicol . 1999;18:560–565
  26. Willems JL , De Bisschop HC , Verstraete AG , et al.   Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate . Arch Toxicol . 1993;67:79–84
  27. Sudakin DL , Mullins ME , Horowitz BZ , Abshier V , Letzig L . Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime . J Toxicol Clin Toxicol . 2000;38:47–50
  28. De Bleecker J , Van den Neucker K , Colardyn F . Intermediate syndrome in organophosphorus poisoning: a prospective study . Crit Care Med . 1993;21:1706–1711
  29. Uehara S , Hiromori T , Suzuki T , Kato T , Miyamoto J . Studies on the therapeutic effect of 2-pyridine aldoxime methiodide (2-PAM) in mammals following organophosphorus compound (OP)-poisoning (report II): aging of OP-inhibited mammalian cholinesterase . J Toxicol Sci . 1993;18:179–183
  30. Eddleston M , Szinicz L , Eyer P , Buckley N . Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials . QJM . 2002;95:275–283
  31. Peter JV , Moran JL , Graham P . Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques . Crit Care Med . 2006;34:502–510
  32. Guven M , Sungur M , Eser B , Sari I , Altuntas F . The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning . J Toxicol Clin Toxicol . 2004;42:617–623

PII: S1016-3190(10)60009-2

doi:10.1016/S1016-3190(10)60009-2

Tzu Chi Medical Journal
Volume 19, Issue 3 , Pages 159-163, September 2007